Lv61
2140 积分 2025-09-17 加入
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease
14天前
已完结
Selenium supplementation in inactive moderate to severe Graves’ orbitopathy patients: a randomized controlled trial
14天前
已完结
The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease
14天前
已完结
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study
14天前
已关闭
Multiple imputation using chained equations: Issues and guidance for practice
14天前
已完结
Natural killer cells that target autoimmune cells linked with protection against multiple sclerosis
14天前
已完结
Immunoregulatory natural killer cells
14天前
已完结
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease
16天前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
16天前
已完结
Graves disease: latest understanding of pathogenesis and treatment options
16天前
已完结